{"name":"Follicum AB","slug":"follicum-ab","ticker":"","exchange":"","domain":"","description":"Follicum AB is a biotechnology company focused on the development of innovative treatments for hair loss and other dermatological conditions. The company's lead product, FOL-005, is currently in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Rare Disease","slug":"rare-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"FOL-005","genericName":"FOL-005","slug":"fol-005","indication":"Androgenetic alopecia (male and female pattern hair loss)","status":"phase_2"}]}],"pipeline":[{"name":"FOL-005","genericName":"FOL-005","slug":"fol-005","phase":"phase_2","mechanism":"FOL-005 is a Wnt/β-catenin signaling activator designed to stimulate hair follicle growth and treat hair loss.","indications":["Androgenetic alopecia (male and female pattern hair loss)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE02eGxVU1dpWlBYa2gzNURkRVJ6QXFTNmh4VUo1U2ZwenFvaDJpc1RwWHFyS29weTJOQklyQVpTSlN6N0RxalpWbmFxSDJIRi1lNlNSczZLUVEydGlZeEQ2Zmln?oc=5","date":"2025-06-12","type":"pipeline","source":"Market.us","summary":"Hair Treatment Drug Market Size, Share | CAGR Of 7.1% - Market.us","headline":"Hair Treatment Drug Market Size, Share | CAGR Of 7.1%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE41X25NeF92SW5YeFNHMEcxTHA2R1k5bVNJanJ2YTRlSzZ6UE9GdEc1ODVkWTYyNkRKMVB3ejZpdzY5WjFtSENtbnFYT3ZxMkswUHlQYzR4TUQtY2c2LXZtbk5wNEU3VVB5dDRjN3p3?oc=5","date":"2021-03-25","type":"pipeline","source":"BioSpace","summary":"BioSpace Movers & Shakers, March 26 - BioSpace","headline":"BioSpace Movers & Shakers, March 26","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFB5VG1IbmRJd3pzU3V0bGd3UHFpNi1UcEM3bHNzeDRYeWtUOHJ1Ql9zS3J3RUFvT1VSemRVOFUzdV82eXljdVZtSHE1ZzJGbU80eDhTM0tLaHhRdlprNW52WmFmSFVBSm9UaDdEdGpLeHc3Wmd3RGRHZU01MlM?oc=5","date":"2020-05-26","type":"pipeline","source":"Fortune Business Insights","summary":"Alopecia Treatment Market Size & Growth Report, 2032 - Fortune Business Insights","headline":"Alopecia Treatment Market Size & Growth Report, 2032","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1OTXI3YjJRbFJqTS1GV0VoV0dyOVdqdm5RdVQxRF9jbldyeEQwVEM5eHVRTW9PWk1TUG1EeHBmRDdXaG9HV0E3SGRtaGJqWDJPenEwdXBXbFplRExpQWVvcnZ1dXE2VkNBLUE?oc=5","date":"2020-01-30","type":"pipeline","source":"PharmaLive","summary":"BioSpace Global Roundup: Jan. 30, 2020 - PharmaLive","headline":"BioSpace Global Roundup: Jan. 30, 2020","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}